1.
UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2
by Bai, Dou-Sheng
Oncotarget, 31 May 2016, Vol.7(22), pp.32946-55

2.
Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma
by Fu, Ting-Ying
Oncotarget, 20 December 2016, Vol.7(51), pp.85097-85108

3.
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
by Li, Jun
Oncotarget, April 20, 2015, Vol.6(11), pp.9551-9563

4.
RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.
by Zhang, Jian
Oncotarget, February 20, 2015, Vol.6(5), pp.3432-3442

5.
Increased expression of αTubulin is associated with poor prognosis in patients with pancreatic cancer after surgical resection.
by Lin, Chao
Oncotarget, September 13, 2016, Vol.7(37), pp.60657-60664

6.
Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis.
by Gong, Liang
Oncotarget, April 5, 2016, Vol.7(14), pp.18458-18468

7.
Massively parallel sequencing and genome-wide copy number analysis revealed a clonal relationship in benign metastasizing leiomyoma
by Wu, Ren-Chin
Oncotarget, 18 July 2017, Vol.8(29), pp.47547-47554

8.
miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2
by Zhou, Yan-Wu
Oncotarget, 24 May 2016, Vol.7(21), pp.30730-47

9.
Genetic polymorphisms in TERT are associated with increased risk of esophageal cancer
by Wu, Yifei
Oncotarget, 07 February 2017, Vol.8(6), pp.10523-10530

10.
CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
by Cao, Yifan
Oncotarget, 21 March 2017, Vol.8(12), pp.20328-20339

11.
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
by Sung, Pi-Lin
Oncotarget, 26 January 2016, Vol.7(4), pp.4036-47

12.
Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells
by Lu, Pei-Hua
Oncotarget, 04 April 2017, Vol.8(14), pp.22800-22810

13.
Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
by Han, Fang
Oncotarget, April 26, 2016, Vol.7(17), pp.24800-24809

14.
Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
by Shao, Chi-Hung
Oncotarget, June 13, 2017, Vol.8(24), pp.38802-38810

15.
Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma.
by Lin, Erh-Hsuan
Oncotarget, April 26, 2016, Vol.7(17), pp.24179-24193

16.
Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages
by Chian, Chih-Feng
Oncotarget, 02 August 2016, Vol.7(31), pp.50582-50595

17.
miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
by Luo, Gang
Oncotarget, November 10, 2015, Vol.6(35), pp.37808-37823

18.
Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macroph...
by Fang, Wei-Yu
Oncotarget, 29 September 2015, Vol.6(29), pp.28401-24

19.
Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer
by Wang, Fubo
Oncotarget, 30 November 2014, Vol.5(22), pp.11091-102
